About
HeroSupport SA is a Swiss medtech company founded in June 2022, focused on enhancing cancer treatment through personalized medical devices. The company specializes in 3D-printed, patient-specific immobilization devices and standardized workflows aimed at improving precision, safety, and accessibility in breast cancer radiotherapy. Originating as a spin-off from Geneva University Hospital, HeroSupport's founders include CEO Giovanna Dipasquale and CTO Johan Uiterwijk. Their flagship product, the VENUS Shell™, is a patented immobilization device tailored to fit each patient's body, enhancing comfort and reproducibility during treatment. Additionally, the company offers an ergonomic imaging table that adapts to individual patients, improving treatment accuracy and reducing discomfort. HeroSupport targets cancer patients undergoing radiotherapy, particularly those with breast cancer, as well as radiation oncology centers and healthcare professionals looking to optimize treatment workflows. The company is committed to sustainability, innovation, and collaboration in its mission to improve cancer care.
Technologies
Keywords
Company Information
- Employees6
- Founded2022
Location
53 Route de l'Uche, Veyrier, Geneva, Switzerland, 1255
